Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
- PMID: 10577640
- DOI: 10.1016/S0140-6736(99)02035-8
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
Abstract
Background: In chronic HIV-1 infection, dynamic equilibrium exists between viral production and clearance. The half-life of free virions can be estimated by inhibiting virion production with antiretroviral agents and modelling the resulting decline in plasma HIV-1 RNA. To define HIV-1 and hepatitis C virus (HCV) dynamics, we used plasma apheresis to increase virion clearance temporarily while leaving virion production unaffected.
Methods: Plasma virus loads were measured frequently before, during, and after apheresis in four HIV-1-infected patients, two of whom were also co-infected with HCV. Rates of virion clearance were derived by non-linear least-square fitting of plasma virus load to a model of viral dynamics.
Findings: Virion clearance rate constants were 0.0063/min (9.1/day) to 0.025/min (36.0/day; half-life 28-110 min) for HIV-1 and 0.0038/min (5.5/day) to 0.0069/min (9.9/day; half-life 100-182 min) for HCV. These values provided estimates of daily particle production of 9.3 log10-10.2 log10 particles for HIV-1 and 11.6 log10-13.0 log10 particles for HCV.
Interpretation: Our findings confirm that HIV-1 and HCV are produced and cleared extremely rapidly. New estimates for HIV-1 clearance are up to ten times higher than previous ones, whereas HCV clearance is similar to previous estimates.
Similar articles
-
Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.J Virol. 2001 Mar;75(6):2597-603. doi: 10.1128/JVI.75.6.2597-2603.2001. J Virol. 2001. PMID: 11222682 Free PMC article.
-
Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.Scand J Infect Dis. 2011 Oct;43(10):798-803. doi: 10.3109/00365548.2011.589077. Epub 2011 Jul 5. Scand J Infect Dis. 2011. PMID: 21728744
-
Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.J Clin Virol. 2006 Jul;36(3):166-76. doi: 10.1016/j.jcv.2005.12.003. Epub 2006 Jan 20. J Clin Virol. 2006. PMID: 16427802
-
Hepatitis C virus kinetics.Antivir Ther. 2000 Jun;5(2):85-90. Antivir Ther. 2000. PMID: 10971860 Review.
-
Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy.Forum (Genova). 2000 Jan-Mar;10(1):32-42. Forum (Genova). 2000. PMID: 10717256 Review.
Cited by
-
Modeling sequence evolution in HIV-1 infection with recombination.J Theor Biol. 2013 Jul 21;329:82-93. doi: 10.1016/j.jtbi.2013.03.026. Epub 2013 Apr 6. J Theor Biol. 2013. PMID: 23567647 Free PMC article.
-
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.AIDS. 2012 Nov 28;26(18):2295-306. doi: 10.1097/QAD.0b013e32835a5c2f. AIDS. 2012. PMID: 23014521 Free PMC article.
-
Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.J R Soc Interface. 2012 Sep 7;9(74):2309-20. doi: 10.1098/rsif.2012.0127. Epub 2012 Mar 14. J R Soc Interface. 2012. PMID: 22417909 Free PMC article.
-
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection.PLoS Comput Biol. 2020 Aug 20;16(8):e1008064. doi: 10.1371/journal.pcbi.1008064. eCollection 2020 Aug. PLoS Comput Biol. 2020. PMID: 32817614 Free PMC article.
-
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19079-84. doi: 10.1073/pnas.0707449104. Epub 2007 Nov 19. Proc Natl Acad Sci U S A. 2007. PMID: 18025463 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical